The growing numerical gap between the number of patients and available human donor organs has led to a revival of interest in xenotransplantation. A number of trials are currently underway, especially pig islet transplantation, the aim of which is to develop transgenic and knockout pigs in which hyperacute rejection (HAR) and acute vascular rejection (AVR) can be overcome. These rejections are strongly related to species-specific glycoantigens.
KeywordsHyperacute Rejection High Mannose Type Acute Vascular Rejection Terminal Glycosylation Perv Infectivity
Unable to display preview. Download preview PDF.
- Miyagawa S, Murakami H, Takahagi Y, Nakai R, Yamada M, Murase A, Koyota S, Koma M, Matsunami K, Fukuta D, Fujimura T, Shigehisa T, Okabe M, Nagashima H, Shirakura R, Taniguchi N (2001) Remodeling of the major pig xenoantigen by N-acetylglucosaminyltransferase III in transgenic pig. J Biol Chem 276:39310–39319PubMedCrossRefGoogle Scholar
- Omori T, Nishida T, Komoda, H, Fumimoto Y, Ito T, Sawa Y, Gao C, Nakatsu S, Shirakura R. Miyagawa S (2006) A study of the xenoantigenicity of neonatal porcine islet-like cell clusters (NPCC) and the efficiency of adenovirus-mediated DAF (CD55) expression. Xenotransplantation 11:237–246Google Scholar